Pardes Biosciences Inc.

NASDAQ: PRDS · Real-Time Price · USD
2.18
0.02 (0.93%)
At close: Aug 30, 2023, 9:59 PM

Pardes Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-96.63M -38.52M
Depreciation & Amortization
-1.06 n/a
Stock-Based Compensation
10.56M 1.22M
Other Working Capital
12.38M -377K
Other Non-Cash Items
-1.06M n/a
Deferred Income Tax
n/a n/a
Change in Working Capital
15.16M 379K
Operating Cash Flow
-71.98M -36.92M
Capital Expenditures
n/a n/a
Cash Acquisitions
n/a n/a
Purchase of Investments
-138.2M n/a
Sales Maturities Of Investments
1.18M n/a
Other Investing Acitivies
n/a n/a
Investing Cash Flow
-137.02M n/a
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
-397K 302.19M
Financial Cash Flow
-397K 302.19M
Net Cash Flow
-209.39M 265.27M
Free Cash Flow
-71.98M -36.92M